The extensive evidence behind DMSO's ability to treat 'incurable' neurological diseases — and how to use it
Story at a Glance:
DMSO is an “umbrella remedy” capable of treating a wide range of challenging ailments due to its combination of therapeutic properties (e.g., improving circulation, reducing inflammation, protecting cells from a myriad of otherwise lethal stressors, and reviving dying cells).
These properties make DMSO uniquely suited to treat “incurable” neurological disorders, and in conjunction with forgotten research on the effects of microcirculatory impairments, reshape our understanding of the causes of neurological (and psychiatric) diseases.
DMSO has shown remarkable promise for cognitive impairment, brain fog, and memory loss from a wide range of causes (e.g., aging, vascular disease, anesthesia, post-COVID or pharmaceutical poisoning), along with improving sleep quality and dream vividness — often by resolving the pain, breathing difficulties, or neurological conditions (e.g., restless leg syndrome) that were preventing restorative sleep.
Extensive data supports DMSO’s use for the major neurodegenerative diseases — including Parkinson’s, Alzheimer’s, ALS, Huntington’s, and multiple sclerosis — and protein misfolding diseases such as prion disorders and Niemann-Pick disease, where DMSO’s ability to act as a chemical chaperone (stabilizing proteins and dissolving toxic aggregates) and augment cranial drainage is particularly relevant.
Numerous psychiatric conditions (e.g., schizophrenia, depression, anxiety, and PTSD) have responded to DMSO, as have seizures and epilepsy, movement disorders, encephalitis, myasthenia gravis, and hydrocephalus.
DMSO has also produced striking developmental improvements in children with Down syndrome across multiple clinical studies, along with many other neurodevelopmental disorders.
This article will synopsize the extensive data demonstrating DMSO’s efficacy for CNS neurological diseases (approximately 2000 studies and 200 pertinent reader testimonials), share pertinent (non-DMSO) discoveries we’ve made about neurological diseases over the years, and then conclude with practical guidance on DMSO protocols and complementary approaches that also aid in the treatment of common neurological disorders.